Cephalotaxine,3,4-didehydro-O2-demethyl-1,- 2-dihydro-O3-methyl- (50908-92-4)
Identification |
Properties |
Safety Data |
|
|
Other Product
- Cephalotaxine,3,4-didehydro-O2-demethyl-1,- 2-dihydro-O3-methyl-
- bis[2-hydroxy-4',5-bis(1-methyl-1-phenylethyl)[1,1'-biphenyl]-3-carboxylato-O2,O3]zinc
- Aluminum,dihydroxy(3-hydroxy-2-naphthalenecarboxylato-O2,O3)-, (T-4)- (9CI)
- Chromate(3-), [3-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-2-hydroxy-5-nitrobenzenesulfonato(3-)][2-hydroxy-3-[[(2-hydroxyphenyl)methylene]amino]-5-nitrobenzenesulfonato(3-)-N3,O2,O3]-, trisodium
- [2-hydroxy-3-[[(2-hydroxyphenyl)methylene]amino]-5-nitrobenzene-1-sulphonato(3-)-N3,O2,O3]chromium
- [4-[(4-chlorophenyl)azo]-3-hydroxynaphthalene-2-carboxylato-O2,O3]copper
- [3-hydroxy-4-(phenylazo)naphthalene-2-carboxylato(2-)-O2,O3]copper
- Copper,(4-bromo-3-hydroxy-2-naphthalenecarboxylato-O2,O3)(8-quinolinolato-N1,O8)-(9CI)
- Copper,(4-bromo-3-hydroxy-2-naphthalenecarboxylato-O2,O3)(5-bromo-8-quinolinolato-N1,O8)-(9CI)
- Copper,(4-bromo-3-hydroxy-2-naphthalenecarboxylato-O2,O3)(5-nitro-8-quinolinolato-N1,O8)-(9CI)
- Copper,(4-bromo-3-hydroxy-2-naphthalenecarboxylato-O2,O3)(5-fluoro-8-quinolinolato-N1,O8)-(9CI)
- Platinum,diammine[L-ascorbato(2-)-O2,O3]-, (SP-4-3)- (9CI)
- Aluminum, (ethyl3-oxobutanoato-O1',O3)[mono(1-methylethyl)1,2-benzenedicarboxylato-O2](2-propanolato)-, (T-4)- (9CI)
- Ferrate(3-),tris[L-ascorbato(2-)-O2,O3]-, trihydrogen (9CI)
- Maytansine,O3-acetyl-O3-de[2-(acetylmethylamino)- 1-oxopropyl]-22-demethyl-
- O3’,O5’-hydroxyphosphoryl-1-methyl-6,N6-didehydro-1,6-dihydro-adenosine
- Antimonate(3-),[2,3-dihydroxybutanedioato(4-)-O2,O3][3-mercapto-L-valinato(2-)-N,S]-, sodiumdihydrogen, [T-4-[R-(R*,R*)]]- (9CI)
- Cephalotaxine,3-[4-methyl (2R)-2-hydroxy-2-(3-methylbutyl)butanedioate]
- O3’,O5’-hydroxyphosphoryl-O2’-methyl-adenosine
- Cephalotaxine,3-[4-methyl (2R,3S)-2,3-dihydroxy-2-(3-methylbutyl)butanedioate]